Conference Coverage

CABG best for diabetes patients with CKD – or is it?

Publish date: September 27, 2016

 

AT THE ESC CONGRESS 2016

bjancin@frontlinemedcom.com

Pages

Recommended Reading

VIDEO: PCSK9 inhibitor can nearly replace need for apheresis in HeFH
MDedge Endocrinology
VIDEO: Moderate LDL, SBP reductions slash cardiovascular events 90% over time
MDedge Endocrinology
VIDEO: Apheresis shows promise for refractory angina with high Lp(a)
MDedge Endocrinology
High free T4 levels linked to sudden cardiac death
MDedge Endocrinology
When 1 + 1 = 3: Rational drug combinations in type 2 diabetes
MDedge Endocrinology
Novel GLP-1 receptor agonist shows reduction in cardiovascular risk
MDedge Endocrinology
Elevated HDL levels predict reduced lung function
MDedge Endocrinology
ESC’s new lipid guidelines keep LDL-cholesterol targets
MDedge Endocrinology
Metabolic dysregulation may predict remission failure in late-life depression
MDedge Endocrinology
Lenvatinib sparked or worsened hypertension in patients with RAI-resistant thyroid cancer
MDedge Endocrinology